Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[POCT-management during the first wave of Covid-19 in France. Results of a national survey leaded by the SFBC-POCT Working Group].
Glady L, Moal V, Benz-De Bretagne I, Bouvier D, Di Giovanni F, Chenevier-Gobeaux C, Jeannesson E, Jolly E, Kadi H, Oueidat N, Pernet P, Pieroni L, Poupon C, Toussaint-Hacquard M, Dubos M, Martinel I, Chauzit E, Beauvieux MC; Membres du groupe de travail « SFBC Marqueurs biochimiques COVID-19 ». Glady L, et al. Among authors: chauzit e. Ann Biol Clin (Paris). 2021 Dec 1;79(6):535-549. doi: 10.1684/abc.2021.1685. Ann Biol Clin (Paris). 2021. PMID: 34961737 French.
[Method validation of a critical parameter in human embryos culture: culture media pH].
Chansel-Debordeaux L, Dagorne V, Mercier M, Soula V, Chauzit E, Dabernat S, Peuchant E, Jimenez C, Papaxanthos-Roche A. Chansel-Debordeaux L, et al. Among authors: chauzit e. Ann Biol Clin (Paris). 2018 Jun 1;76(3):251-258. doi: 10.1684/abc.2018.1349. Ann Biol Clin (Paris). 2018. PMID: 29862968 Free article. French.
Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome.
de Montalembert M, Ribeil JA, Brousse V, Guerci-Bresler A, Stamatoullas A, Vannier JP, Dumesnil C, Lahary A, Touati M, Bouabdallah K, Cavazzana M, Chauzit E, Baptiste A, Lefebvre T, Puy H, Elie C, Karim Z, Ernst O, Rose C. de Montalembert M, et al. Among authors: chauzit e. PLoS One. 2017 Mar 3;12(3):e0172147. doi: 10.1371/journal.pone.0172147. eCollection 2017. PLoS One. 2017. PMID: 28257476 Free PMC article.
Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study.
Ravaud A, Gomez-Roca C, Picat MQ, Digue L, Chevreau C, Gimbert A, Chauzit E, Sitta R, Cornelis F, Asselineau J, Aziza R, Daste A, Quemener C, Baud J, Bikfalvi A, Pedenon-Périchout D, Doussau A, Molimard M, Delord JP. Ravaud A, et al. Among authors: chauzit e. Eur J Cancer. 2017 Nov;85:39-48. doi: 10.1016/j.ejca.2017.07.031. Epub 2017 Sep 5. Eur J Cancer. 2017. PMID: 28886476 Clinical Trial.
A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours.
Adenis A, Ray-Coquard I, Italiano A, Chauzit E, Bui-Nguyen B, Blay JY, Tresch-Bruneel E, Fournier C, Clisant S, Amela EY, Cassier PA, Molimard M, Penel N. Adenis A, et al. Among authors: chauzit e. Br J Cancer. 2013 Nov 12;109(10):2574-8. doi: 10.1038/bjc.2013.648. Epub 2013 Oct 22. Br J Cancer. 2013. PMID: 24149182 Free PMC article. Clinical Trial.
Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial.
Mir O, Cropet C, Toulmonde M, Cesne AL, Molimard M, Bompas E, Cassier P, Ray-Coquard I, Rios M, Adenis A, Italiano A, Bouché O, Chauzit E, Duffaud F, Bertucci F, Isambert N, Gautier J, Blay JY, Pérol D; PAZOGIST study group of the French Sarcoma Groupe-Groupe d'Etude des Tumeurs Osseuses (GSF-GETO). Mir O, et al. Among authors: chauzit e. Lancet Oncol. 2016 May;17(5):632-41. doi: 10.1016/S1470-2045(16)00075-9. Epub 2016 Apr 5. Lancet Oncol. 2016. PMID: 27068858 Clinical Trial.